Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: have had a severe migraine headache; The pain was so bad that I was not able to open my eyes; The pain was so bad that I was not able to open my eyes, walk or talk; The pain was so bad that I was not able to open my eyes, walk or talk; The pain was so bad that I was not able to open my eyes, walk or talk; I still have a full headache; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 05Feb2022 10:00 (Formulation: solution for injection, Lot number: FJ1614) at the age of 42 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hashimoto" (unspecified if ongoing), notes: Other medical history: Hashimoto; "Insulin resistant" (unspecified if ongoing), notes: Other medical history: Insulin resistant. Concomitant medication(s) included: DROSPIRENONE/ETHINYLESTRADIOL; METFORMIN; SYNTHROID. Vaccination history included: Bnt162b2 (Dose Number: 1, Prev dose Batch/Lot No: FJ1614, Prev dose Vaccine Administration Time: 02:00 PM, Prev dose Location of injection: Arm Right), administration date: 15Jan2022, when the patient was 42 years old, for Covid-19 Immunization, reaction(s): "I experienced pain at the injection site", "redness at the injection site", "had chills and night sweats", "had chills and night sweats", "fever", "headache", "Body aches", "swelling at the injection site". The following information was reported: MIGRAINE (non-serious) with onset Feb2022, outcome "recovering", described as "have had a severe migraine headache"; APRAXIA (non-serious) with onset Feb2022, outcome "recovered" (Feb2022), described as "The pain was so bad that I was not able to open my eyes"; GAIT INABILITY (non-serious), MUTISM (non-serious) all with onset Feb2022, outcome "recovered" (Feb2022) and all described as "The pain was so bad that I was not able to open my eyes, walk or talk"; PAIN (non-serious) with onset Feb2022, outcome "recovering", described as "The pain was so bad that I was not able to open my eyes, walk or talk"; HEADACHE (non-serious) with onset Feb2022, outcome "not recovered", described as "I still have a full headache". Therapeutic measures were taken as a result of migraine, apraxia, gait inability, mutism, pain, headache.  Additional information: The patient had a severe migraine headache. It started 12 hours after receiving second dose. The pain was so bad that she was not able to open my eyes, walk or talk. The pain was debilitating for 24 hours. The pain was still there- not completely gone- but tolerable. She was now able to talk, open eyes, and walk. But still have a full headache. The patient have been taking aspirin, Excedrin migraine, ibuprofen, Tylenol, caffeine, and advil for the headache. No complete relief yet. Prior to vaccination, patient has not been diagnosed with COVID-19. Patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, patient has not tested for COVID-19.  No follow-up attempts are possible. No further information is expected.